why choose us

First received: April 20, 2026

Clinical Trial: Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hepatic Impairment and Healthy Female

Study Type: INTERVENTIONAL


Official Title: Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function

Brief Summary: This study is a Phase I, single-dose, open-label trial designed to evaluate the pharmacokinetics and safety of a single oral dose of 25 mg VC005 tablets in participants with mild and moderate hepatic impairment compared to participants with normal hepatic function.

Read more